<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04317898</url>
  </required_header>
  <id_info>
    <org_study_id>analgesia in chronic PMPs</org_study_id>
    <nct_id>NCT04317898</nct_id>
  </id_info>
  <brief_title>Ultrasound-Guided Serratus Plane Block Vs Paravertebral Block For Chronic Post-mastectomy Pain.</brief_title>
  <official_title>Ultrasound-Guided Serratus Plane Block Vs Paravertebral Block For Chronic Post-mastectomy Pain.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      compare the analgesic efficacy between ultrasound paraverbral block and serratus block in&#xD;
      post mastectomy pain.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is reported that postmastectomy pain syndrome (PMPS) is a common problem, ranging from 25%&#xD;
      to 60%.&#xD;
&#xD;
      The pain is localized in the axilla, medial upper arm, breast, and/or chest wall and lasting&#xD;
      beyond three months after surgery when all other causes of pain such as infection have been&#xD;
      eliminated.&#xD;
&#xD;
      The pain seriously affects the patient's mood, everyday activities, and social function and&#xD;
      causes heavy economic burden for the healthcare system.&#xD;
&#xD;
      Postmastectomy pain syndrome (PMPS) itself is not a specific diagnosis but rather describes a&#xD;
      cluster of symptoms frequently observed in breast cancer survivors following treatment.&#xD;
&#xD;
      Many patients will experience short-term nociceptive pain after breast cancer treatment.&#xD;
      However, with PMPS, patients frequently experience persistent neuropathic-type pain: burning,&#xD;
      tingling, aching, a subjective sense of &quot;tightness&quot; around the chest wall, or even phantom&#xD;
      breast or nipple pain. Neuropathic pain results from dysfunction of the peripheral nerves&#xD;
      caused by surgery, radiation, or neurotoxic chemotherapies.&#xD;
&#xD;
      Currently, there are a wide variety of approaches to treat this type of pain. physical&#xD;
      therapy has been employed as a modality to improve physical function.&#xD;
&#xD;
      As far as interventional procedures, intercostal nerve blockade, stellate ganglion blockade,&#xD;
      and paravertebral blockade have all been utilized with varying degrees of success.&#xD;
&#xD;
      Paraverberal blocks have superseded thoracic epidurals when it comes to choice of a regional&#xD;
      anaesthesia technique to provide analgesia for breast surgery.&#xD;
&#xD;
      The injection of local anaesthetic solution in the paravertebral space results in a&#xD;
      unilateral block, which is sensory, motor, and sympathetic. The uptake of the local&#xD;
      anaesthetic solution is enhanced due to the absence of fascial sheaths binding the spinal&#xD;
      nerves.&#xD;
&#xD;
      Another potential target for an interventional procedure for chronic pain after treatment for&#xD;
      breast cancer is the serratus plane. The serratus plane block is a novel ultrasound-guided&#xD;
      nerve block, which is able to anesthetize the hemithorax.&#xD;
&#xD;
      The serratus plane block relies on the fact that there are branches of the intercostal nerves&#xD;
      following within 2 potential spaces, one superficial and one deep, surrounding the serratus&#xD;
      anterior muscle. The serratus anterior muscle arises as strips from the first 9 ribs and&#xD;
      converges posteriorly on the scapula to form the medial wall of the axilla.&#xD;
&#xD;
      The innervation of the serratus anterior muscle is via the long thoracic nerve (Bell's&#xD;
      nerve), and the nerve itself is covered by the fascia of the serratus anterior muscle and&#xD;
      lies anterior to the muscle.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2020</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients gaining ≥ 50% pain reduction at VAS Score from baseline value.</measure>
    <time_frame>baseline</time_frame>
    <description>Compare the analgesic efficacy between ultrasound paraverbral block and serratus block in chronic postmastectomy pain.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Post-mastectomy Pain Syndrome</condition>
  <arm_group>
    <arm_group_label>serratus plane block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20 ml of Bupivacine 0.25% +80mg triamcinlone will be injected in serratus plane under ultrasound.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>paravertebral block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>10 ml of bubivacine 0.25% +80 mg triamcinlone will be injected at T2 level (paravertebral) under ultrasound.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>serratus plane block by ultra-sound</intervention_name>
    <description>To perform Serratus block, patients will be placed in the lateral decubitus position with the affected side facing up, or in the prone position with the affected side facing the operator . After sterile preparation, a linear ultrasound probe will be utilized to identify the latissimusdorsi and serratus anterior muscles in a sagittal plane. The plane superficial to the serratus anterior muscle and below the latissimusdorsi muscle will be identified. The skin will be topicalized with 1 mL of 1% lidocaine using a 30-gauge needle. Using an in-plane approach, a 25-gauge 1.5-cm needle will be used to inject a total of 20-mL of 0.25% bupivacaine with 80 mg of triamcinlone under direct ultrasound visualization.</description>
    <arm_group_label>serratus plane block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paravertebral block by ultra-sound</intervention_name>
    <description>TPVB will be given using high frequency linear US transducer, place the probe parallel to the vertebral spine at T2 level and shifted 2-3 cm laterally to obtain the appropriate visualization. Following the identification of plura, transverse process and paravertebral space, the needle will be inserted in caudocranial direction using in-plane approach. Confirm negative vessel or pleural breach via aspiration then proceed with local anaesthetic 10ml of 0.25% bubivacine and 80mg triamcinlone slowly; the pleura will be seen to be pushed downward.</description>
    <arm_group_label>paravertebral block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients have postmastectomy pain of neuropathic nature, DN4&#xD;
&#xD;
               -  4 for at least 3ms duration.&#xD;
&#xD;
          -  The intensity of postmastectomy pain on VAS score ≥ 5.&#xD;
&#xD;
          -  Unsatisfactory treatment with 1st line antineuropathic drugs, Pregabalin(150 mg daily)&#xD;
             or Deloxetine(60mg daily).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Infection of the skin at or near site of needle puncture.&#xD;
&#xD;
          -  Coagulopathy .&#xD;
&#xD;
          -  Drug hypersensitivity or allergy to the studied drugs.&#xD;
&#xD;
          -  Central or peripheral neuropthy .&#xD;
&#xD;
          -  Significant organ dysfunction .&#xD;
&#xD;
          -  Morbid obesity (BMI&gt;35kg/m2) .&#xD;
&#xD;
          -  Vertebral anomalies.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohammed Mohammed Abd El-Latif, Prof of Anesthesia</last_name>
    <role>Study Director</role>
    <affiliation>Mohammed MohammedAbd El-Latif</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ashraf Amin Mohammed, Prof of Anesthesia</last_name>
    <role>Study Director</role>
    <affiliation>Ashraf Amin Mohammed</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rania Mohammed Abd El-Emam, Lecturer of Anesthesia</last_name>
    <role>Study Director</role>
    <affiliation>Rania Mohammed Abd El-Emam</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aya Abo Eldahab Ali Eldein, Resident</last_name>
    <phone>01068744428</phone>
    <email>totaaboeldahab8@gmail.com</email>
  </overall_contact>
  <reference>
    <citation>Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA. 2009 Nov 11;302(18):1985-92. doi: 10.1001/jama.2009.1568. Erratum in: JAMA. 2012 Nov 21;308(19):1973.</citation>
    <PMID>19903919</PMID>
  </reference>
  <reference>
    <citation>Smith WC, Bourne D, Squair J, Phillips DO, Chambers WA. A retrospective cohort study of post mastectomy pain syndrome. Pain. 1999 Oct;83(1):91-5.</citation>
    <PMID>10506676</PMID>
  </reference>
  <reference>
    <citation>Couceiro TC, Menezes TC, Valênça MM. Post-mastectomy pain syndrome: the magnitude of the problem. Rev Bras Anestesiol. 2009 May-Jun;59(3):358-65. Review. English, Portuguese.</citation>
    <PMID>19488550</PMID>
  </reference>
  <reference>
    <citation>Peuckmann V, Ekholm O, Rasmussen NK, Groenvold M, Christiansen P, Møller S, Eriksen J, Sjøgren P. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain. 2009 May;13(5):478-85. doi: 10.1016/j.ejpain.2008.05.015. Epub 2008 Jul 16.</citation>
    <PMID>18635381</PMID>
  </reference>
  <reference>
    <citation>Fernández-Lao C, Cantarero-Villanueva I, Fernández-de-Las-Peñas C, del Moral-Ávila R, Castro-Sánchez AM, Arroyo-Morales M. Effectiveness of a multidimensional physical therapy program on pain, pressure hypersensitivity, and trigger points in breast cancer survivors: a randomized controlled clinical trial. Clin J Pain. 2012 Feb;28(2):113-21. doi: 10.1097/AJP.0b013e318225dc02.</citation>
    <PMID>21705873</PMID>
  </reference>
  <reference>
    <citation>Wijayasinghe N, Andersen KG, Kehlet H. Neural blockade for persistent pain after breast cancer surgery. Reg Anesth Pain Med. 2014 Jul-Aug;39(4):272-8. doi: 10.1097/AAP.0000000000000101. Review.</citation>
    <PMID>24918332</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2020</study_first_posted>
  <last_update_submitted>July 14, 2020</last_update_submitted>
  <last_update_submitted_qc>July 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Aya Abo eldahab Ali elden</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

